Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116496215A reveals efficient Pd-catalyzed route for quinolinone intermediates offering significant cost reduction and scalable manufacturing capabilities for global pharmaceutical supply chains and procurement teams.
Efficient one-step synthesis of N-acyl indoles using Pd catalysis and solid CO sources. High yield, mild conditions ideal for API intermediates.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles offers high yield and scalability for pharmaceutical intermediates.
Patent CN111423381B details a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with significant cost reduction potential.
Patent CN114751883B details efficient palladium-catalyzed carbonylation. Delivers high-purity intermediates with streamlined supply chain and cost advantages.
Patent CN111423381A details a mild Pd-catalyzed carbonylation for 2-trifluoromethyl imidazoles, offering reliable pharma intermediate supply with enhanced metabolic stability.
Patent CN114478375A details a novel Pd-catalyzed reductive aminocarbonylation route. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112239456B details a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering safer processing and high yields for API intermediates.
Patent CN121159431A reveals a novel nickel catalyzed method for delta aminoketone derivatives ensuring cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation for tetrahydro-beta-carbolinones, offering a cost-effective alternative to palladium methods for API intermediates.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and cost reduction.
Novel palladium-catalyzed route offers mild conditions and significant cost reduction in pharmaceutical intermediate manufacturing for global supply chains and strategic partners.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel nickel-catalyzed method offers cost-effective supply chain solutions for high-purity intermediates without noble metals.
Patent CN112480015B reveals a novel one-pot Pd-catalyzed method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and high purity.
Discover a novel nickel-catalyzed method for synthesizing alpha,beta-unsaturated thioesters using arylsulfonyl chlorides. A cost-effective, scalable solution for pharma intermediates.
Novel Pd-catalyzed carbonylation method for high-purity benzofuran acetamide intermediates. Reduces cost and simplifies supply chain for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation patent CN115286628B offers efficient synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel Pd-catalyzed method for 2-trifluoromethyl quinazolinones offers high yields and broad substrate scope for efficient drug molecule synthesis.